Both, the traditional clinical trial path and the BeCare App virtual trial solution can help bring drugs to market and improve patient outcomes. However, the BeCare solution is quicker, more efficient, less expensive, and provides outcome measures based on quantitative data.
A May 2023 trial recruitment underscores how BeCare Link can be a valuable resource for pharmaceutical companies and CROS running clinical trials. In one week, BeCare Link recruited 75 MS patients for a 12-week trial by leveraging BeCare MS Link’s user base.